Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: An analysis of the united network of organ sharing database

Circulation

Volumn 114, Issue 21, 2006, Pages 2280-2287

  Russo, Mark J ^a,b   Chen, Jonathan M ^a   Hong, Kimberly N ^a   Stewart, Allan S ^a   Ascheim, Deborah D ^a,b   Argenziano, Michael ^a   Mancini, Donna M ^a   Oz, Mehmet C ^a   Naka, Yoshifumi ^a,c  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Milstein Hospital   (United States)

Author keywords

Diabetes mellitus; Heart failure; Outcomes; Risk factors; Transplantation

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

ADULT; AGED; CAUSE OF DEATH; CORONARY ARTERIOSCLEROSIS; DATABASES, FACTUAL; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; HEART; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; INFECTION; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE; MALE; MIDDLE AGED; TISSUE AND ORGAN PROCUREMENT;

EID: 33751249907     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.615708     Document Type: Article

References (16)

1. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996-1002.
2. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 1994;72:S3-S9.
3. Centers for Disease Control and Prevention (CDC). Incidence of end-stage renal disease among persons with diabetes: United States, 1990-2002. MMWR Morb Mortal Wkly Rep. 2005;54:1097-1100.
4. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial. JAMA. 1997;278:2069-2074.
5. Moss SE, Klein R, Klein BE. Long-term incidence of lower-extremity amputations in a diabetic population. Arch Fam Med. 1996;5:391-398.
6. Almdal T; Scharling H; Jensen JS; Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164:1422-1426.
7. Morgan JA, John R, Weinberg AD, Colletti NJ, Mancini DM, Edwards NM. Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg. 2004;127:1486-1492.
8. Marelli D, Laks H, Patel B, Kermani R, Marmureanu A, Patel J, Kobashigawa J; University of California at Los Angeles Heart Transplant Group. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant. 2003;22:1091-1097.
9. Klingenberg R, Gleissner C, Koch A, Schnabel PA, Sack FU, Zimmermann R, Katus HA, Dengler TJ. Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect. J Heart Lung Transplant. 2005;24:1239-1246.
10. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant. 2004;23:S187-S193.
11. Costanzo MR, Augustine S, Bouge R. Selection and treatment of candidates for heart transplantation. Circulation. 1995;92:3593-3612.
12. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
13. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, Heitjan DF, Meier P, Ascheim DD, Levitan RG, Weinberg AD, Stevenson LW, Shapiro PA, Lazar RM, Watson JT, Goldstein DJ, Gelijns AC. The REMATCH trial: rationale, design, and end points: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thoracic Surg. 1999;67:723-730.
14. Rhenman MJ, Rhenman B, Icenogle T, Christensen R, Copeland J. Diabetes and heart transplantation. J Heart Transplant. 1988;7:356-358.
15. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC, O'Connor GT, Ross CS; Northern New England Cardiovascular Disease Study Group. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110(suppl II):II-41-II-44.
16. Herlitz J, Wognsen GB, Karlson BW, Sjoland H, Karlsson T, Caidahl K, Hartford M, Haglid M. Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus. Coron Artery Dis. 2000;11:339-346.